-
May 11, 2022 MindMed’s Phase 2 LSD Trial Treating Anxiety Was a SuccessResearchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.
-
May 10, 2022 Why Wednesday Will Be Biggest Day of 2022 for Psychedelic InvestorsPsychedelic investors are about to see pivotal data presented on flagship programs by the titans...
-
May 6, 2022 Wesana Health May Sell Clinics to Focus Solely on Drug Development: An AnalysisWesana Health reaches a major strategic pivot point. Our resident Psychedelic Investor examines what this...
-
May 4, 2022 Fungus Among Us: 5 Fascinating Facts About MushroomsScience just keeps discovering how cool and beneficial mushrooms are, with or without psilocybin.
-
May 2, 2022 Elon Musk Excites Psychedelic Industry CEOs with This TweetThis is one of the billionaire's most explicit acknowledgments of the power of psychedelics for...
-
April 29, 2022 Why Field Trip Health Is Dividing in Two — and What This Means for InvestorsField Trip Health plans to split into two independent, publicly traded companies: Field Trip Health...
-
April 28, 2022 MAPS Navigates Multiple Scandals: Why Health Canada Is Reviewing MDMA TrialsA sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader...
-
April 22, 2022 Understanding 3 Risks of Investing in Psychedelic StocksNo one is responsible for your financial future, other than yourself, so be responsible with...
-
April 21, 2022 Kevin O’Leary Predicts These 3 Psychedelic Companies Will Merge, But Should They?Our resident Psychedelic Investor James Hallifax wonders if the "Shark Tank" star's prediction makes financial...
-
April 20, 2022 5 Examples of Ancient Psychedelic Cave ArtAncient civilizations have been using psychedelic substances, like psilocybin, for millenniums, and the proof is...
